logo
Tele2 AB (0QE6) Receives a Hold from Kepler Capital

Tele2 AB (0QE6) Receives a Hold from Kepler Capital

In a report released on July 3, Kristoffer Carleskar from Kepler Capital maintained a Hold rating on Tele2 AB, with a price target of SEK150.00. The company's shares closed last Thursday at SEK138.75.
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Carleskar covers the Communication Services sector, focusing on stocks such as Tele2 AB, Telia Company AB, and Telenor. According to TipRanks, Carleskar has an average return of 3.5% and a 75.00% success rate on recommended stocks.
Currently, the analyst consensus on Tele2 AB is a Hold with an average price target of SEK139.50, which is a 0.54% upside from current levels. In a report released on July 2, Deutsche Bank also maintained a Hold rating on the stock with a SEK122.00 price target.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cannabis Stocks Surge as President Trump Considers Reclassifying the Drug
Cannabis Stocks Surge as President Trump Considers Reclassifying the Drug

Business Insider

time22 minutes ago

  • Business Insider

Cannabis Stocks Surge as President Trump Considers Reclassifying the Drug

Cannabis stocks are surging after President Trump said earlier today that his administration is looking at whether to reclassify marijuana as a less dangerous drug, with a decision likely to come in the next few weeks. While 45 states have already legalized marijuana in some form, either for medical or recreational use, it is still considered a Schedule I drug at the federal level. This category, which was created under the Controlled Substances Act of 1970, labels marijuana as highly dangerous, addictive, and without accepted medical use. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. However, the idea of changing that classification has been ongoing for several years. Indeed, in 2022, then-President Joe Biden told the Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) to review marijuana's status. HHS later recommended in 2023 that it be moved to Schedule III, and in 2024, the DEA proposed a rule to make the change. Interestingly, moving marijuana to Schedule III would put it in the same category as drugs like Tylenol with codeine or anabolic steroids, which can be prescribed by licensed medical professionals and filled at pharmacies. If this change happens, it would be the most significant shift in federal marijuana policy since the drug was first banned, although it would not make recreational use legal nationwide. Nevertheless, Trump said that the choice is not straightforward, as it means balancing the potential medical benefits with concerns about its broader impact on society. 'Some people like it, some people hate it. Some people hate the whole concept of marijuana,' he said, noting how divided public opinion remains. Which Cannabis Stock Is the Better Buy? Turning to Wall Street, out of the four stocks pictured below, analysts think that TCNNF stock has the most room to run. In fact, TCNNF's average price target of $14.09 per share implies more than 87% upside potential. On the other hand, analysts expect the least from CURLF stock, as its average price target of $3.03 equates to a gain of 14.5%.

Woodside Energy Group (WDS) Receives a Hold from Macquarie
Woodside Energy Group (WDS) Receives a Hold from Macquarie

Business Insider

time22 minutes ago

  • Business Insider

Woodside Energy Group (WDS) Receives a Hold from Macquarie

Macquarie analyst Mark Wiseman maintained a Hold rating on Woodside Energy Group today and set a price target of A$27.50. The company's shares closed today at A$27.02. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Wiseman covers the Energy sector, focusing on stocks such as Woodside Energy Group, Santos Limited, and Boss Energy . According to TipRanks, Wiseman has an average return of 6.3% and a 53.33% success rate on recommended stocks. In addition to Macquarie, Woodside Energy Group also received a Hold from Morgan Stanley's Robert Koh in a report issued on August 4. However, on July 29, Jarden maintained a Buy rating on Woodside Energy Group (ASX: WDS). The company has a one-year high of A$27.77 and a one-year low of A$18.61. Currently, Woodside Energy Group has an average volume of 5.12M. Based on the recent corporate insider activity of 16 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of WDS in relation to earlier this year.

Citi Remains a Buy on Genius Sports Limited (GENI)
Citi Remains a Buy on Genius Sports Limited (GENI)

Business Insider

time22 minutes ago

  • Business Insider

Citi Remains a Buy on Genius Sports Limited (GENI)

Citi analyst Jason Bazinet maintained a Buy rating on Genius Sports Limited today and set a price target of $16.00. The company's shares closed today at $12.52. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Bazinet is a 5-star analyst with an average return of 16.4% and a 63.15% success rate. Bazinet covers the Communication Services sector, focusing on stocks such as Electronic Arts, Walt Disney, and Netflix. In addition to Citi, Genius Sports Limited also received a Buy from Financial's Josh Nichols in a report issued on August 7. However, on August 6, TR | OpenAI – 4o downgraded Genius Sports Limited (NYSE: GENI) to a Hold. Based on Genius Sports Limited's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $143.99 million and a GAAP net loss of $8.2 million. In comparison, last year the company earned a revenue of $119.72 million and had a GAAP net loss of $25.54 million Based on the recent corporate insider activity of 20 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of GENI in relation to earlier this year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store